Archives

Roughly 15 years ago, scientists first mapped the human genome, leading many to believe that this would usher in a new age of personalized therapies to treat cancer and many other diseases. [...]

Published in Crain’s Chicago Business, September 29, 2016 – On a shelf behind Eric Lefkofsky’s desk are bound copies of the closing documents of the three companies he’s taken public, Groupon, [...]

  Tempus is a health-tech company that enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. Tempus provides genomic [...]